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Abstract
Differential DNA methylation is an essential epigenetic signal for gene regulation, development, and disease processes. We
mapped DNA methylation patterns of 190 gene promoter regions on chromosome 21 using bisulfite conversion and
subclone sequencing in five human cell types. A total of 28,626 subclones were sequenced at high accuracy using (long-
read) Sanger sequencing resulting in the measurement of the DNA methylation state of 580427 CpG sites. Our results show
that average DNA methylation levels are distributed bimodally with enrichment of highly methylated and unmethylated
sequences, both for amplicons and individual subclones, which represent single alleles from individual cells. Within CpG-rich
sequences, DNA methylation was found to be anti-correlated with CpG dinucleotide density and GC content, and
methylated CpGs are more likely to be flanked by AT-rich sequences. We observed over-representation of CpG sites in
distances of 9, 18, and 27 bps in highly methylated amplicons. However, DNA sequence alone is not sufficient to predict an
amplicon’s DNA methylation status, since 43% of all amplicons are differentially methylated between the cell types studied
here. DNA methylation in promoter regions is strongly correlated with the absence of gene expression and low levels of
activating epigenetic marks like H3K4 methylation and H3K9 and K14 acetylation. Utilizing the single base pair and single
allele resolution of our data, we found that i) amplicons from different parts of a CpG island frequently differ in their DNA
methylation level, ii) methylation levels of individual cells in one tissue are very similar, and iii) methylation patterns follow a
relaxed site-specific distribution. Furthermore, iv) we identified three cases of allele-specific DNA methylation on
chromosome 21. Our data shed new light on the nature of methylation patterns in human cells, the sequence dependence
of DNA methylation, and its function as epigenetic signal in gene regulation. Further, we illustrate genotype–epigenotype
interactions by showing novel examples of allele-specific methylation.
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Introduction
After deciphering the sequence of the human genome, the study
of epigenetic processes which initiate and maintain heritable
patterns of gene expression and gene function without changing
the DNA sequence, has moved into the center of research [1]. The
epigenome comprises different modifications of histone proteins
including acetylation, ubiquitination, phosphorylation and meth-
ylation working in concert with methylation of the DNA [2,3]. In
mammals, DNA methylation predominantly occurs at CpG
dinucleotides, the majority of which are methylated under normal
cell conditions [4]. CpG sites are underrepresented in the human
genome but cluster in CpG-islands which overlap with the
annotated transcriptional start sites (TSS) of about 70% of all
human genes [5] and mostly are unmethylated in normal
differentiated cells [6]. DNA methylation has been shown to play
important roles in the regulation of gene expression, development,
genomic imprinting, X chromosome inactivation, and genome
stability [7–9]. Erroneous DNA methylation contributes to the
development of human cancer and multifactorial diseases [10–12].
Various high-throughput technologies for the analysis of DNA
methylation in human genomes have been developed recently
[13,14]. In principle, these technologies are based on three
approaches to discriminate the methylated and unmethylated
cytosines in CpG sites. 1) Digestion of genomic DNA with
methylation sensitive restriction enzymes to discriminate and/or
enrich methylated and unmethylated DNA and employ two-
dimensional electrophoresis [15], PCR [16], microarray [17] or
paired-end sequencing [18] for analysis. These methods only
provide methylation data related to the restriction enzyme
recognition sites. 2) Enrichment of methylated or unmethylated
fractions of genomic DNA with antibodies against methylated
PLoS Genetics | www.plosgenetics.org 1 March 2009 | Volume 5 | Issue 3 | e1000438cytosine, methyl-CpG binding domains or other protein domains
and readout by microarray or DNA sequencing [19–23]. The
resolution of this approach is limited by the fragment size. 3)
Bisulfite conversion of DNA leading to the selective deamination
of cytosine but not 5-methyl cytosine [24,25] and the sequencing
of subsequently generated PCR products either directly [26] or
after subcloning as done here. Next generation ultra-deep
sequencing methods were recently used for the analysis of the
bisulfite converted genomic DNA from Arabidopsis [27,28], as
well as for analysis of bisulfite converted DNA enriched for CpG
island sequences in mouse [29]. The suitability of these methods
for establishing reference maps of DNA methylation has been
evaluated recently in silico [30].
The sequencing of subcloned single DNA molecules, as carried
out in this study, provides the most reliable and detailed
information of the methylation pattern for every single CpG site
in a relatively long region of about 300 to 500 base pairs (bps),
when analyzed by conventional Sanger sequencing. Furthermore,
it provides qualitative and quantitative information of allele-
specificity of DNA methylation. Drawbacks of this method are the
relatively high costs for conventional Sanger sequencing and the
time-consuming need to establish suitable primers for each
amplicon of interest. Therefore, we focused our work on
chromosome 21, which is the smallest human autosome. It is of
special biomedical relevance due to its association with genetic
diseases including trisomic 21 causing Down syndrome, which is
the most common genetic cause of reduced cognitive abilities.
Results
Overview of the Results
We aimed to establish a comprehensive map of DNA
methylation at promoter regions on chromosome 21. All
protein-coding genes on chromosome 21 annotated in Ensembl,
UCSC and RefSeq gene were investigated in a window from
2000 bps upstream to 500 bps downstream of the annotated
transcriptional start site for CpG density and GC content. For this
study, we selected genes which show an enriched CpG density in
their promoter region. This includes genes which contain a CpG
island in their promoter as defined by the widely used Takai/Jones
criteria [31] and also genes with weaker CpG islands [20,32,33].
To increase coverage, we investigated more than one amplicon for
a subset of genes, in particular for those with well-annotated
alternative transcriptional start sites (TSS).
In total, we analyzed the DNA methylation pattern of 297
amplicons from 190 gene promoters by using bisulfite conver-
sion, subcloning and sequencing as the major experimental
method. The study was performed in five cell types, viz. human
peripheral blood (mainly leukocytes), fibroblast, the human
embryo kidney cell line HEK293, the human hepatocellular liver
carcinoma cell line HepG2 and fibroblast cells derived from a
patient with Down syndrome (trisomic 21). A statistical summary
of the analysis is provided in Table 1. All methylation data
obtained here are presented in an integrated web platform (http://
biochem.jacobs-university.de/name21/) for visualization and
download which also includes additional technical information.
Furthermore, the results are provided as custom annotation tracks
to be displayed in the UCSC Genome Browser [34].
Cell Type Specific Differences in DNA Methylation
The DNA methylation levels of all amplicons in all studied cell
types are shown in Figure 1A. Methylation of some of our
amplicons has been studied previously. In such cases, our data in
general fit well with previous results obtained for the overlapping
DNA region in the same tissues (Text S1). 57% (168/297) of the
amplicons show similar methylation level (methylation difference
,30%) in all five cell types. The remaining amplicons are
differentially methylated between two or more cell types. We
clustered all five cell types according to their average DNA
methylation levels for all amplicons (Figure 1C). The results show
that DNA methylation levels are more similar between related cell
types, e.g. between transformed cell line HEK293 and cancer cell
line HepG2 and between the two types of primary cells used here,
blood and fibroblasts. As seen previously, the average CpG island
methylation in cultured cells or cancer cell lines is higher than in
primary tissues [29,35,36]. We tested the effect of 5-azacytidine
treatment on methylated regions in the HEK293 cells. As shown
in Figure 1B and Text S2, we observed a heterogeneous response
in which about 40% of the amplicons were massively demethyl-
ated but about 10% were almost completely refractory to
demethyation.
As shown in Figure 1D, the methylation levels of all amplicons
studied showed a bimodal distribution with an enrichment of
highly methylated and unmethylated sequences, a result that as
has been observed previously as well [20,26,29]. Most of our
amplicons are situated in promoter regions and show low
methylation (62% of them having methylation levels ,30%).
However, 25% of the amplicons are highly methylated with
methylation levels .70%. The bimodal methylation level
distribution was also observed at the level of the individual CpG
sites and clones analyzed (Figure 1D).
Comparison of Normal and Trisomic 21 Fibroblasts
Trisomic cells are expected to exhibit an 1.5-fold increase in
gene expression levels when compared to normal cells. However, it
is known that epigenetic modifications can alter such effects. For
example, DNA methylation is involved in dosage compensation by
X-chromosome inactivation in females [37]. To test if similar
compensatory effects are mediated by methylation changes of the
promoters on chromosome 21 in trisomic patients, we investigated
DNA methylation patterns in trisomic fibroblasts and compared it
Author Summary
Epigenetics is defined as the inheritance of changes in
gene function without changing the DNA sequence.
Epigenetic signals comprise methylation of cytosine bases
of the DNA and chemical modifications of the histone
proteins. DNA methylation plays important roles in
development and disease processes. To investigate the
biological role of DNA methylation, we analyzed DNA
methylation patterns of 190 gene promoter regions on
chromosome 21 in five human cell types. Our results show
that average DNA methylation levels are distributed
bimodally with enrichment of highly methylated and
unmethylated sequences, indicating that DNA methylation
acts in a switch-like manner. Consistent with the well-
established role of DNA methylation in gene silencing, we
found DNA methylation in promoter regions strongly
correlated with absence of gene expression and low levels
of additional activating epigenetic marks. Although
methylation levels of individual cells in one tissue are very
similar, we observed differences in DNA methylation when
comparing different cell types in 43% of all regions
analyzed. This finding is in agreement with a role of DNA
methylation in cellular development. We identified three
cases of genes that are differentially methylated in both
alleles that illustrate the tight interplay of genetic and
epigenetic processes.
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(corresponding to 169 genes) can be compared between trisomic
and normal fibroblast cells. The results indicate that only a small
number of amplicons (7 out of 252) are differentially methylated
with a methylation difference .30% (in fact, trisomic fibroblast
and normal fibroblast were most similar among all pairs of cell
types studied here). Therefore, DNA methylation does not appear
to be a general mechanism of global gene dosage correction in
cells trisomic for chromosome 21. The data from trisomic
fibroblast cells were not included in the following analyses in
order to prevent statistical overweighting of fibroblast methylation
data.
Analysis of the Stability of DNA Methylation Levels
Using our high-quality set of DNA methylation profiles with
single base pair and single allele resolution, we addressed the
question of the stability of natural DNA methylation patterns. To
this end, a subset of data was extracted only containing the PCR
Table 1. Summary of the Data.
genes analyzed 190
cell types analyzed 5
amplicons analyzed 297
mean amplicon length [bps]
1 274
mean number of CpG sites per amplicon
1 21.3
mean GC content per amplicon
1 0.64
mean CpG density per amplicon
1 0.74
PCR products obtained for the different amplicons in the tissues analyzed 1426
subcloned PCR products 1390
mean number of clones per PCR product 20.6
clones analyzed 28626
pyrosequencing or direct sequencing of PCR products 36
CpG sites analyzed in all cell types 29984
CpG sites cloned and sequenced 580427
1In this calculation the primer sequences were not considered.
doi:10.1371/journal.pgen.1000438.t001
Figure 1. Summary of the DNA methylation data. (A) Clustered heatmap of the DNA methylation levels of all amplicons studied in HEK293,
HepG2, leukocytes, fibroblast, and trisomic fibroblast cells, ordered by the average level of DNA methylation and similarity across tissues. (B) DNA
methylation levels of selected highly methylated amplicons in HEK293 after treatment of the cell line with 5-azacytidine (for detail, see Text S2). (C)
Tissue similarity plot comparing the methylation patterns of all five cell types studied here. The numbers represent pair wise Pearson correlation
coefficients between each pair of cell types, calculated using the average DNA methylation levels for all amplicons. (D) Bimodal distribution of the
DNA methylation level of all amplicons, clones, and CpG sites.
doi:10.1371/journal.pgen.1000438.g001
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PLoS Genetics | www.plosgenetics.org 3 March 2009 | Volume 5 | Issue 3 | e1000438Figure 2. Analysis of DNA methylation patterns of amplicons. (A) Average methylation levels of clones were extracted and compared with
the average methylation level of the corresponding PCR product. (B) Extreme types of possible patterns of DNA methylation being either distributed
in a site-specific manner or stochastically. (C) Average methylation levels of all CpG sites from all PCR products were compared with the average
DNA Methylation Analysis of Chromosome 21 Genes
PLoS Genetics | www.plosgenetics.org 4 March 2009 | Volume 5 | Issue 3 | e1000438products with unimodal distribution of methylation levels among
the clones and average methylation levels between 20 and 80%.
Then, we compared the methylation levels of all clones from each
PCR product in the set with the average methylation level of the
respective PCR product (Figure 2A). Our data show that the
methylation levels of clones from each particular PCR product
were very similar to the average of the respective PCR product
indicating that the methylation levels of individual cells from one
tissue are similar.
Analysis of the Distribution of DNA Methylation
We then examined the type of the DNA methylation pattern.
There were two extreme possibilities, with the methylation either
distributed in a site specific pattern (meaning that each site is either
fully methylated or unmethylated) or in a stochastic pattern which
would predict that the average methylation of each site equals the
average methylation of the PCR product (Figure 2B). A stochastic
pattern would only preserve the average methylation of clones but
not the sites of methylation. Visual inspection of the data ruled out
a strict site specific pattern. To determine if the methylation is
stochastically distributed or if there are particular preferences to
methylate some sites, we extracted the average methylation levels
of all CpG sites of PCR products from the unimodal set and
compared to the average methylation level of the respective PCR
products. As shown in Figure 2C, the results significantly differ
from what would be expected by a stochastic distribution, because
the average methylation levels of sites cluster at levels higher and
lower than the average methylation level of the corresponding
PCR product. To further examine the statistical significance of this
finding, the p-value of the methylation patters of each site was
calculated by exact binominal test assuming a stochastic
methylation pattern. As shown in Figure 2D, the fraction of sites
with small p-values was much larger than statistically expected.
We conclude that the methylation level of CpG sites is not strictly
site specific, but there are significant differences in the methylation
of individual sites, which cannot be explained by statistical
fluctuation – we call it a relaxed site specific pattern.
Differential DNA Methylation within Different Parts of
Single CpG Islands
We often observed that amplicons next to each other in the
same CpG island had different methylation states (see Figure 3 for
an example). In our data set there are 164 examples, where more
than one amplicon located on one CpG island was studied in one
of the non-trisomic cell types. In 35 of these cases (21%), the
amplicons were differentially methylated (with a methylation
difference .30%). Differential methylation within one CpG island
happened more often in HEK293 (13 out of 41, 32%) and HepG2
cells (11 out of 41, 27%), than in fibroblast cells (6 out of 40, 15%)
and leukocytes (5 out of 42, 12%). It was reported that there is an
unmethylated core region surrounding TSS within 1 kb of genes
[26]. We checked if the amplicons on the same CpG island also
show such tendency. Among the 35 cases with methylation
difference on the same CpG island, 11 were not informative,
because there are either two TSSs for one gene or different TSSs
for two genes annotated. Hence it was not possible to determine
the distance between TSS and amplicon. In 20 out of the
remaining 24 cases (83%), we observed the methylation of
amplicons gradually decreased when approaching the TSS of
the respective gene both from upstream and downstream. An
example for this is shown in Figure 3.
Correlation of DNA Methylation with DNA Sequence
The GC content and CpG density are two critical properties for
the biological effects of CpG islands. We calculated the GC
content and CpG density of all studied amplicons and compared
with DNA methylation. As shown in Figure 4A, the amplicons
with high GC content and CpG density tend to be low methylated
while those with low GC content and CpG density tend to be
highly methylated, which is consistent with previous results
[20,26,29].
The correlation between periodic distribution of CpG and DNA
methylation has been reported recently [38]. We studied the
distribution of CpG pairwise distances in all amplicons in our
dataset. We observed three significantly overrepresented CpG
distances of 9, 18, and 27 bps in highly methylated (.70%)
amplicons, when comparing with low methylated (,30%)
amplicons (Figure 4B). Simulations using data sets in which the
observed DNA methylation levels were randomly connected to the
amplicon sequences, indicated that these overrepresentations are
highly significant with p-values ,1.1610
24 (Figure 4B). The same
result was also obtained after separating amplicons for methylation
,50% and .50% (data not shown). The overrepresentation of
pairs of CpG sites in distances of 9 bps and multiples of this in the
sequence of highly methylated DNA could be correlated to the
preference of the DNMT3a DNA methyltransferase for methyl-
ation of CpG pairs in that particular distance [38,39].
With our large dataset of methylation states of CpG sites, we
studied the effect of flanking sequence on DNA methylation. The
flanking sequences (20 bases) of each methylated CpG site were
collected using different methylation thresholds (Figure 5 and Text
S3) and the occurrences of all four bases at each position were
compared with the flanking sequences of all CpG sites used as
reference. The results revealed that several bases at different
positions were significantly over- or underrepresented in the
flanking sequences of methylated CpG sites with p-values
,1.25610
24 (Text S3). These differences were reproducible
when using different thresholds of methylation level (Text S3) and
using different combinations of data from only two or three cell
types (data not shown). No statistically significant fluctuations were
detected when using randomized methylation data for the same
analysis. From the overall point of view, A/T flanks correlate with
DNA methylation while G/C flanks are correlated with the
absence of DNA methylation. This result reflects the previous
observation that bona fide CpG islands with high GC content and
CpG density tend to be unmethylated while non-CpG islands tend
to be methylated (see above). However, it is noteworthy that this
tendency was not equally observed at all flanking positions.
Inverse Correlation of DNA Methylation with Gene
Expression
DNA methylation is known to lead to gene silencing [8].
However, so far this observation was mainly based on experiments
with individual genes. We compared our gene promoter
methylation data with gene expression data extracted from a
serial analysis of gene expression (SAGE) database [40]. Matching
methylation level of the respective PCR products, indicating that methylation levels of sites are not stochastically distributed. (D) The methylation
patterns of all CpG sites were extracted and for each site the probability of the observed pattern calculated assuming a model of stochastic
distribution. The distribution was plotted indicating a significant enrichment of sites with unexpected methylation pattern.
doi:10.1371/journal.pgen.1000438.g002
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types, high methylation of amplicons is correlated with low gene
expression, and high gene expression is correlated with low
methylation (Figure 6A), demonstrating that DNA methylation
and gene expression are inversely correlated. Some methylated
amplicons from expressed genes have been excluded from this
analysis, because there was more than one amplicon analyzed for
that particular gene and at least one was found to be unmethylated
or because there were alternative start sites annotated for the gene
(Text S4).
The distribution of RNA polymerase II pre-initiation complex
(PIC) is another indicator of gene expression. Kim et al (2005)
mapped the PIC binding sites across the genome by immunopre-
cipitation of TFIID-bound DNA from primary fibroblast cells
[41]. We extracted all 92 PIC binding positions that are within
2.5 kb of the annotated TSS of genes on chromosome 21. These
PIC binding sites are related with 69 gene promoters, out of which
67 genes (with 93 amplicons) are with DNA methylation data.
95% of these gene promoters (88 out of 93) exhibit low levels of
DNA methylation (,30%) in fibroblast. Comparing with the
proportion of low methylated genes in the whole dataset of
fibroblast (67%), the absence of DNA methylation is highly
significant in the genes occupied with PIC (with p-values ,10
210
according to exact binominal test) (Figure 6B). The absence of
methylated genes in the PIC occupancy data set is consistent with
the inhibitory role of DNA methylation on gene expression.
Correlation of DNA Methylation with Other Chromatin
Marks
Beside DNA methylation, histone modification is another
important mechanism of epigenetic regulation of gene expression.
Therefore, we assessed the correlation of DNA methylation and
the following histone modifications: (i) histone H3 lysine 4
trimethylation (H3K4me3) and (ii) histone H3 lysine 9 and 14
acetylation (H3K9ac/H3K14ac), all of which are known as
activating marks [3]. Their distributions were mapped across the
nonrepetitive portions of chromosome 21 and 22 in HepG2 cells
[42], which allowed us to correlate them with the HepG2 DNA
methylation data. The distances between the regions with DNA
methylation data and histone modifications were calculated up to
10 kb. The results indicate a strong correlation between the
absence of DNA methylation and the presence of H3K4me3 and
H3K9ac/K14ac, up to distances of 1 kb (Figure 7A).
Polycomb-mediated histone H3K27 methylation was found to
pre-mark genes for de novo methylation in cancer [43,44]. Suz12
is one core subunit of PRC2 and is essential for its activity. A
genome-wide mapping of Suz12 binding sites in human
embryonic stem (ES) cells revealed that Suz12 is enriched at a
Figure 3. Example of amplicons located on the same CpG island but showing different DNA methylation levels and decreasing
methylation when approaching the TSS of the gene. The figure shows the position of these amplicons in the UCSC genome browser in the
lower part and it schematically displays the methylation pattern of five amplicons determined in HEK293 in the upper part. Each row corresponds to
one sequenced clone of the bisulfite PCR product. Each column corresponds to one CpG site. The color code indicates the methylation state of the
individual CpG site in each clone.
doi:10.1371/journal.pgen.1000438.g003
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content. (B) Overrepresentation of distances between CpG sites in the sequences of highly methylated DNA as compared to low methylated. The
occurrences of all distances of CpG sites were counted in highly methylated (HM) amplicons and low methylated (LM) amplicons. Then, the ratio of
both numbers (HM/LM) was plotted versus the distance in bps (shown in black). The same calculation was performed 12 times with randomized
methylation level of all amplicons (shown in light gray). The simulations were used to derive the p-value of the overrepresentation of the peaks at
9 bps (p-value ,2.0610
25), 18 bps (p-value ,1.5610
28) and 27 bps (p-value ,1.1610
24).
doi:10.1371/journal.pgen.1000438.g004
Figure 5. Over- and under-representation of bases in the flanks of methylated CpG sites using different threshold of DNA
methylation ($90%, $80%, $70%, or $60%). The numbers indicate how often a significant p-value was observed in the four data sets. Here
only data are shown which were significantly biased with all four tested thresholds. Green and red colors indicate that the base is significantly over-
or under-represented, respectively, in the flanks of methylated CpG sites. As an example, the p-values observed for overrepresentation of flanking
nucleotides at methylation levels $90% are shown in Text S3.
doi:10.1371/journal.pgen.1000438.g005
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maintain pluripotency of ES cells and preferentially activated
during ES cell differentiation [45]. It was also demonstrated that
Suz12 co-occurred with histone H3K27 trimethylation at most
genes [45]. We extracted the published Suz12 binding data on
chromosome 21 and correlated them with our DNA methylation
data. 17 amplicons from 13 genes were exactly overlapping with
Suz12 binding sites (Text S5). We observed that almost half of all
amplicons with polycomb binding show increased methylation in
the cancer cell line HepG2 and/or the transformed cell line
Figure 7. Correlation of DNA methylation and histone modification. (A) Association of low DNA methylation levels with high levels of
histone H3K4me3 and histone H3K9ac/K14ac. The distances between literature-derived H3K4me3 and H3K9ac/K14ac sites in HepG2 cells and
amplicons studied in this project were calculated. The fractions of amplicons with different methylation level were plotted for various distances. (B)
Enrichment of polycomb binding sites in amplicons with increased methylation in HEK293 or HepG2 cells as compared to fibroblasts or leukocytes.
The figure displays the fraction of amplicons with increased methylation (.30%) within the whole data set (light grey bars) and within Suz12 bound
amplicons (black bars) (which is indicative of polycomb binding). p-values are given for each comparison.
doi:10.1371/journal.pgen.1000438.g007
Figure 6. Correlation of DNA methylation and gene expression. (A) Inverse correlation of DNA methylation and gene expression. DNA
methylation data obtained in HEK293 and leukocytes were plotted against the normalized SAGE expression data in the respective cell type. (B)
Inverse correlation of DNA methylation and PIC binding. The p-value for the enrichment of unmethylated genes in the amplicons with PIC binding
was calculated by exact binomial test.
doi:10.1371/journal.pgen.1000438.g006
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compared to the whole dataset where only about 15% show
increased methylation (Figure 7B).
Analysis of Functional Categories of Genes
To check the biological functions associated with genes having
methylated or unmethylated promoters, we analyzed the gene
ontology (GO) categories of genes with methylated promoter
(.50%) in at least one of the cell types, genes that were low
methylated (,30%) in all studied cell types and genes with
differentially methylated promoter among cell types (methylation
difference .30% in at least three pair wise comparisons) by using
GOTM (Gene Ontology tree machine: http://bioinfo.vanderbilt.
edu/gotm/) [46]. All genes analyzed with GO annotations were
used as reference list. The analysis revealed that genes with
methylated or unmethylated promoters are significantly overrep-
resented in distinct GO categories (Figure 8). The genes with
methylated promoters are overrepresented in ‘‘sensory percep-
tion’’ and ‘‘physiological response to stimulus’’ categories or they
encode for structural genes like collagens while unmethylated
genes are significantly overrepresented in ‘‘transferase activity’’
and ‘‘ATP binding’’ categories. Genes with differentially methyl-
ated promoters are overrepresented in ‘‘immune response’’ and
‘‘cell-cell signalling’’ categories.
Detection of Allele-Specific DNA Methylation
Different methylation levels of the two alleles of one gene within
one cell (allele-specific DNA methylation) has been observed in
imprinting regions, where methylation of one allele occurs on a
parent of origin basis [47] and in X chromosome inactivation in
females [48]. There are also reports about sequence dependent
allele-specific methylation in non-imprinted loci the in human
genome [49]. Using our single allele resolution DNA methylation
dataset, we checked for the presence of allele-specific DNA
methylation on chromosome 21. To this end, the data were
filtered for a biphasic distribution of DNA methylation levels. Hits
were then manually inspected for the occurrence of SNPs in the
sequenced region which can be used to differentiate the alleles.
Our results indicated the presence of allele-specific methylation in
three regions in leukocytes derived from a healthy individual
(Figure 9 and Text S6).
Two amplicons (176_1 and 176_2) on a CpG island overlapping
with the first exon of the CBR1 gene (carbonyl reductase 1)
showed strong allele-specific methylation in leukocytes (Figure 9A).
Figure 8. Gene ontology analysis of genes with different methylation states.
doi:10.1371/journal.pgen.1000438.g008
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66%), while G allele was low methylated (average: 7%). For
amplicon 176_1 about half of the clones showed a deletion and
were partially methylated, while all clones without the deletion
were unmethylated. This result suggests that the allele-specific
methylation spans the whole CpG island. In other tissues, we did
not observe a SNP in these amplicons. In HepG2, biphasic
methylation was observed, while in HEK293 and fibroblast both
amplicons were completely unmethylated (Text S6).
Amplicon 23_2 located on the first exon of gene C21orf81
showed massive allele-specific methylation in leukocytes with the A
and C alleles methylated to 28% and 94% on average (Figure 9B).
Figure 9. Allele-specific DNA methylation. (A) Allele-specific methylation of two amplicons (176_1 and 176_2) in the promoter of the CBR1
gene. For 176_1 clones were sorted according to the presence of a deletion (dbsnp rs41563015) in the bisulfite sequencing results. For 176_2, the
clones were sorted according to the presence of C/G SNP (dbsnp rs25678). (B) Allele-specific methylation of amplicon 23_2 from gene C21orf81. A/C
SNP (dbsnp rs56270809) was used to differentiate alleles. The positions of all SNP sites are indicated by arrows. Each row corresponds to one clone of
bisulfite PCR products. Each column corresponds to one CpG site in the studied region. The color codes indicate the different methylation states of
each CpG site in each clone. See Text S6 for details on the methylation patterns of these amplicons in other tissues analyzed.
doi:10.1371/journal.pgen.1000438.g009
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biphasic methylation in leukocytes, but did not contain an SNP.
In other tissues, no allele-specific methylation was observed (Text
S6). Amplicon 197_intern located in an internal region of gene
DSCR3 showed ASM in leukocytes with the A allele either being
methylated or unmethylated and the C allele always being
unmethylated (Text S6). This result agrees with data obtained
by Yamada et al (2004) who identified this region of allele-specific
methylation in blood previously [16]. For this amplicon, fibroblast
and trisomic fibroblast contained the SNP but were both
unmethylated, HepG2 showed only the A allele and was
unmethlylated and HEK293 showed biphasic methylation but
only contained the C allele.
Discussion
For many years, it was believed that CpG islands are mainly
unmethylated and there exists little difference in the DNA
methylation of different cell types. Here, we show for five different
cell types that CpG islands frequently are methylated and that
there is a substantial difference in the methylation pattern of
different cell types. Based on the most commonly used criteria for
defining CpG islands (GC content $55% and CpG observed vs.
expected $0.65 [31]), 14% of the amplicons on CpG islands show
dense methylation in different cell types. We also observe that a
significant number of CpG islands exhibit substantial differences in
their average DNA methylation levels in different parts. This result
underscores the importance of the position where DNA methyl-
ation is studied, in order to draw valid biological conclusions. Our
data confirm that high levels of DNA methylation in CpG rich
promoters are strongly associated with down-regulation of gene
expression. However, the inverse relation does not hold, because
there are many examples of unmethylated genes that are not
expressed, possibly due to lack of expression caused by other
mechanisms than DNA methylation like absence of the relevant
activating transcription factors.
With bisulfite subcloning and sequencing technology, we
provide methylation data at single-allele resolution, which makes
it possible to investigate cell-specific mosaicism and allele-specific
methylation patterns. Methylation levels of different cells in the
same tissue are very similar in general. We observed allele-specific
methylation at two regions on chromosome 21 that were not
identified before and also confirmed allele specific methylation at
one region previously shown to be specifically methylated in the
maternal allele [16]. Interestingly, our data show that allele-
specific methylation in all three cases is not observed in all tissues
analyzed. Further studies have to determine if the methylation
differences were due to parent of origin dependent methylation
that has been lost in some tissues or if some tissues underwent
allele-specific methylation changes that were triggered by the
genetic polymorphisms between the two alleles, which would
provide an example of genotype-epigenotype interactions. Allele-
specific methylation might contribute to allele-specific expression
that is a widespread phenomenon in the human genome [50,51].
There are interesting connections between DNA sequence and
DNA methylation. We and others observed a strong anti-
correlation of DNA methylation with CpG density and GC
content, indicating that DNA methylation declines the more the
sequence resembles a CpG island [20,26,29]. This trend is also
reflected in our flanking sequence preferences of DNA methylation
showing that highly methylated CpG sites are flanked by A/T rich
sequences while unmethylated ones tend to be embedded in G/C
rich sequences. The underlying mechanism of this phenomenon is
not clear at present, however, the flanking sequence preferences
suggest that not all neighboring base pairs are of equal importance
for the DNA methylation state. One potential connection between
DNA methylation and DNA sequence could be the flanking
sequence preferences of the DNA methyltransferases. We observed
an overrepresentation of A at 21 and T at +1 flanking position
which agrees with the experimental flanking preferences of
Dnmt3a and 3b [52]. This observation suggests a potential link
to the sequence preference DNMT3a and 3b and confirms a
similar conclusion based on a smaller data set [52] although
preferences observed here at larger distances to the CpG site are
slightly different, which is most likely due to the smaller amount of
data used in the previous analysis.
Dnmt3a and 3L have been shown to form heterotetramers with
two active sites in a distance of 8–10 bps and both Dnmt3a/3L
and Dnmt3a tend to co-methylate CpG sites in that distance
[38,39]. The similar periodicity in the occurrence of CpG sites was
also observed in the differentially methylated regions from 12
maternally imprinted mouse genes [38]. In the Arabidopsis genome,
a periodicity of 10 nucleotides was found for CHH methylation
[27]. Here, we observe for the first time a genome wide
enrichment of pairs of CpG sites in distances of 9, 18 and
27 bps in highly methylated DNA when compared to unmethy-
lated DNA. This effect could be due to the preferential
methylation of sites in such distances. The occurrence of multiples
of 9 could be related to the multimerisation and protein
nucleofilament formation observed with Dnmt3a and Dnmt3a/
3L [38,39].
However, our results clearly illustrate that DNA methylation is a
dynamic mark, the pattern of which cannot be explained at the
level of the DNA sequence alone, because 43% of the amplicons
(129 out of 297) showed significant differences in DNA
methylation between at least two out of the five cell types
analyzed. In extrapolation to the total number of cell types in the
human body, it is likely that most of the CpG islands will show
differential methylation in some cell types. DNA methylation is
tightly connected to other forms of epigenetic signaling. We
observed a strong anti-correlation of DNA methylation and
histone H3K4me3 and H3K9ac/K14ac indicating that these
activating marks and the repressive DNA methylation mark are
mutually exclusive at the genomic scale. Similarly as reported
previously [21,53], we observe that methylation of polycomb
marked genes tends to be increased in cancer or transformed cells
suggesting that polycomb signaling is connected to DNA
methylation, perhaps by recruitment of DNA methyltransferases
by polycomb proteins. Our data also shed some light on the
biological function of epigenetic gene regulation. Unmethylated
genes are significantly overrepresented in functional categories,
which suggest important metabolic functions of these unmethy-
lated genes similarly as originally proposed for CpG island
associated genes [54]. The functional categories of genes with
methylated promoters suggest that DNA methylation has an
important effect of on regulation of cell type specific genes
determining both cellular physiology and morphology.
Materials and Methods
Cell Culture and Genomic DNA Extraction
Blood DNA was extracted using QiaAmp Blood DNA Mini kits
(Qiagen). Human embryo kidney (HEK293) cells were grown in
Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% (v/v)
fetal bovine serum (FBS) at 37uC in 5% (v/v) CO2. Human
hepatocellular carcinoma cells HepG2 (ATCC: HB 8065) were
cultured in 90% RPMI 1640 supplemented with 10% FBS at
37uC in 5% (v/v) CO2. Fibroblast cells (CCD-1059SK) were
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supplemented with 10% FBS at 37uC in 5% (v/v) CO2. Trisomic
21 fibroblast cells (Coriell Cell Repositories: AG08941) were
grown in EMEM with Earle’s salts and non-essential amino acids
supplemented with 15% FBS at 37uC in 5% (v/v) CO2. The
genomic DNA from cells was extracted using QIAamp DNA Mini
kit (Qiagen). For the demethylation treatment of HEK293 cells,
2 mM 5-azacytidine was added to the media. During three days of
treatment, the media was exchanged daily and cells were
harvested five days after starting the experiment.
Bisulfite Conversion, Subcloning, and Sequencing
Bisulfite methylation analysis was performed basically as
described [55]. Briefly, the CpG island searcher program
(http://www.cpgislands.com) [56] or the CpGPlot program
(http://www.ebi.ac.uk/Tools/emboss/cpgplot/index.html) were
used to check the presence of a CpG island or CpG rich
region in gene promoter. RepeatMasker software (http://www.
repeatmasker.org) was used to identify the presence of repeat
sequences. Bisearch (http://bisearch.enzim.hu) [57] and Methpri-
mer (http://www.urogene.org/methprimer/index1.html) [58]
programs were used to design primers. For bisulfite conversion,
200–300 ng genomic DNA were digested with BamHI or SphI
(40 U) at 37uC overnight, converted with bisulfite as described
[55] and used for PCR. The PCR products were purified by
ChargeSwitch PCR Clean-Up Kit (Invitrogen) and subcloned
using the StrataClone kit (Stratagene). Around 40 clones for each
amplicon were picked and sequenced. Plasmid DNA of clones was
isolated by an automated alkaline lyses procedure, which includes
template purification by PEG-precipitation and subsequently
adjustment to similar molarity. DNA sequences were determined
using ABI BigDye Terminator chemistry (BigDye Terminator
v3.1 K) and 3730xl ABI 96-capillary sequencer systems equipped
with capillaries of 50 cm separation length. The BiQ analyzer
software was used to perform quality control and to derive DNA
methylation patterns from the sequencing results [59]. BDPC was
used to present the methylation pattern, prepare the figures and
WEB presentation and compile methylation data [60].
Flanking Sequence Analysis
The flanking sequences (20 bases) of each methylated or
unmethylated CpG site in all amplicons (from non-trisomic cell
types) were extracted using different thresholds of methylation
level ($90%, $80%, $70% and $60%). The over- or under-
representation of bases (observed/expected) in the flanks of
methylated CpG sites was analyzed with Microsoft Excel
BINOMDIST function. The flanking sequences of all CpG sites
were used as reference. Figure 5 and Text S3 summarize the bases
with significant p-value (p-value ,1.25610
24 corresponding to p-
value ,0.01 when considering Bonferroni multiple testing
correction) by using four different thresholds. For an additional
statistical validation, we randomized the methylation data of CpG
sites 10 times and extracted the respective (randomized) flanking
sequences. No significant p-value was observed for the flanking
sequences from the randomized datasets. We also performed the
analysis by using different combination of data from only three cell
types and still observed the same results.
Correlation of CpG Periodicity and DNA Methylation
The distance distribution of pairwise distances between CpG
site and the frequency of observed/expected of all pairwise
distances was determined in all amplicon sequences within
distances of 2–200 bps using the DISTRIDIST program
(http://biochem.jacobs-university.de/cgi/distridist.cgi). Ampli-
cons with low GC (#0.55) and observed/expected CpG
dinucleotide content (#0.65) were excluded from this analysis,
because the poor CpG density of them could have caused a bias in
the data analysis. For each distance value, the ratio of averaged
observed/expected CpG pairwise distances was calculated com-
paring highly methylated amplicons (HM, 70%–100% methyla-
tion) with low methylated amplicons (LM, 0–30% methylation).
This ratio (HM/LM) reflects the over- or underrepresentation of
CpG pairwise distances in the highly methylated amplicons as
compared to low methylated amplicons. Since there was no
difference in results between the different cell types, data were
finally averaged over all cell types. To determine the statistical
significance of the data, we randomized the methylation level of all
amplicons 12 times and performed the same calculation. The
randomized distributions were used to derive standard deviation
and mean and to calculate p-values assuming normal distribution.
DNA Methylation and PIC Occupancy
The TFIID binding positions on chromosome 21 in IMR90
fibroblast cells were extracted from published results [41] and
converted from NCBI Build 34 to NCBI Build 36. The p-value for
the enrichment of unmethylated genes in the amplicons with PIC
binding, comparing to the whole dataset, was calculated assuming
a binomial distribution.
Gene Functional Category Analysis
The analysis was performed using GOTM (http://bioinfo.
vanderbilt.edu/gotm/), which is based on hypergeometric test to
show the overrepresented gene ontology categories (p-value
,0.01) [46]. 148 out of 190 genes studied on chromosome 21
were used as reference gene list for the statistical analysis. The
other 42 genes are without functional annotation in GOTM, so
they could not be included in the analysis. The p-value was also
calculated according to BINOMDIST function on the basis of the
overrepresentation of gene ontology categories in methylated,
unmethylated or differentiately methylated genes when comparing
to all genes, as a confirmation of the significance of results.
Correlation of DNA Methylation and Histone Modification
The published histone H3K4me3 and H3K9ac/K14ac mod-
ification data in HepG2 cells with a p-value ,10
24 were extracted
[42] and the positions of them were converted from NCBI Build
33 to NCBI Build 36. The minimal distance was calculated
between regions with DNA methylation and histone modification
data. All amplicons correlated with histone H3K4me3 or
H3K9ac/K14ac were used as reference to show the normal
distribution of amplicons according to methylation level.
DNA Methylation and Polycomb Protein Binding
The published SUZ12 binding data on chromosome 21 in ES
cells were extracted from supplementary table S7 of Lee et al.,
2006 [45]. Only amplicons which are exactly overlapping with
SUZ12 binding sites were included in this analysis. The different
proportions of higher methylated (methylation increase .30%)
amplicons in HepG2 or HEK 293 cells, comparing to that in
normal leukocytes and fibroblast cells, in whole dataset and in
amplicons with SUZ12 binding were calculated respectively. The
p-value was calculated based on BINOMDIST function.
Gene Expression Data Analysis
The SAGE database (http://cgap.nci.nih.gov/SAGE/
AnatomicViewer) presents ranked expression data for different
cell types [40]. For each gene the relative tag occurrence as tag per
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the key task in this experiment, because one has to discriminate
low expression caused by an intrinsically weak promoter from low
expression caused by silencing of a strong promoter. Therefore, we
quantified the expression potential of each promoter using the six
highest expression levels of each gene. This maximal expression
was then used to normalize the expression level in HEK293 and
leukocytes, which resulted in a percentage of gene expression.
Normalized expression data were then compared with the
methylation data.
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